Form 8-K - Current report:
SEC Accession No. 0000882095-25-000015
Filing Date
2025-05-08
Accepted
2025-05-08 17:26:08
Documents
13
Period of Report
2025-05-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gild-20250507.htm   iXBRL 8-K 65585
  Complete submission text file 0000882095-25-000015.txt   190740

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20250507.xsd EX-101.SCH 1795
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20250507_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20250507_pre.xml EX-101.PRE 12521
15 EXTRACTED XBRL INSTANCE DOCUMENT gild-20250507_htm.xml XML 2812
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 25927518
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)